Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 18, Issue 25, Pages 3721-3730Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161212802002760
Keywords
CD36; stroke; angiogenesis; inflammation; endothelial dysfunction
Categories
Funding
- NIH grants [HL82511, HL82511-04S1]
Ask authors/readers for more resources
Stroke pathology involves multifactorial pro-death responses, including inflammation, oxidative stress, vascular dysfunction, and activation of necrotic and apoptotic pathways. The interruption of a single specific pathway in defined stroke model systems has not been sufficient to address the multifactorial nature of stroke-induced injuries in the human population. CD36 is a class B scavenger receptor that functions in regulating normal physiological and pathological functions. CD36 pathways are activated by several distinct ligands. Convergence of these pathways results in inflammatory responses and endothelial dysfunction, which may be an underlying cause of cardio- and cerebrovascular diseases. The current review describes receptor CD36-ligand interactions relevant to endothelial function and discusses how targeting CD36 may have therapeutic utility in stroke.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available